World has launched MiniKit 2.0 on World Chain, introducing a technical upgrade aimed at standardizing development across web and World App environments while enhancing transaction speed, payments, and developer incentives. The release is positioned as a step toward simplifying application deployment and scaling within the World ecosystem, which focuses on consumer-facing applications tied to proof-of-human… Continue reading MiniKit 2.0 launches on World Chain, boosting speed and dev reach
Stock Research
Why Nvidia stock is surging over 3% today
Nvidia shares surged more than 3% on Tuesday, tracking a broader recovery in equities as investor sentiment improved. The Dow Jones Industrial Average jumped 533 points, or 1.2%, while the S&P 500 gained 1.5%. The Nasdaq Composite rose 2%, led by strength in technology stocks. The rally followed reports suggesting a potential de-escalation in the… Continue reading Why Nvidia stock is surging over 3% today
Constellation stock falls as weak outlook, deal delays dent sentiment
Shares of Constellation Energy declined on Tuesday, pressured by weaker-than-expected earnings guidance and the absence of new data center deals at a closely watched investor update. The stock fell about 8.3% after the company forecast 2026 adjusted earnings below analyst expectations, adding to investor concerns about its growth trajectory in an increasingly competitive market. Weak… Continue reading Constellation stock falls as weak outlook, deal delays dent sentiment
US banks raise costs for private credit funds as valuation fears grow: report
US banks are raising borrowing costs for some loans to private credit funds amid growing concerns over valuations, a shift that could pressure returns and curb new lending, according to a Reuters report. The higher pricing is showing up in back leverage facilities tied to business development companies, or BDCs, reversing a period of compressing… Continue reading US banks raise costs for private credit funds as valuation fears grow: report
Nvidia just invested in Marvell stock: should you too?
Marvell Technology Inc (NASDAQ: MRVL) is inching higher after Nvidia announced a [MONEY value=”2000000000″ currency=”usd” notation=”long” replace=”false”] direct investment and a strategic partnership with the custom chips specialist. MRVL pushed past its 20-day moving average (MA) today as investors reacted to this monumental vote of confidence that will see NVDA integrate the firm’s tech into… Continue reading Nvidia just invested in Marvell stock: should you too?
As US tech stocks fall on AI and war fears, are valuations attractive now?
US megacap technology stocks, long the driving force behind a bull run spanning more than three years, are undergoing a sharp valuation reset as a mix of geopolitical tensions, rising yields, and questions around artificial intelligence spending weigh on sentiment. The pullback has intensified in recent weeks, with the sector already under pressure before the… Continue reading As US tech stocks fall on AI and war fears, are valuations attractive now?
Barclays names top 4 defensive stocks to weather global uncertainty
As Dow Jones slides into the “correction territory” and the benchmark S&P 500 index logs its fifth consecutive week of losses, investors are increasingly desperate for a port in the storm. According to Barclays’ senior analyst Andrew Ferremi, the market has shifted into a new, volatile era where geopolitical tensions, oil price spikes, and AI-driven… Continue reading Barclays names top 4 defensive stocks to weather global uncertainty
Dow Jones jumps 380 points as Iran de-escalation hopes lift stocks
US stocks rose on Tuesday, as investors responded positively to signs of potential de-escalation in the Middle East conflict, even as oil prices remained elevated and broader market risks persisted. The Dow Jones Industrial Average climbed 380 points or 0.8%, while the S&P 500 and Nasdaq 100 also advanced more than 1%. The gains followed… Continue reading Dow Jones jumps 380 points as Iran de-escalation hopes lift stocks
Novo cuts Ozempic, Wegovy prices up to 48% as generics surge
Novo Nordisk cut prices for its diabetes and weight-loss injections Ozempic and Wegovy in India on Tuesday, marking a second reduction aimed at countering cheaper local generics. The company lowered list prices by up to 36% for Ozempic and up to 48% for Wegovy, with the move following the March 20 expiry of India’s patent… Continue reading Novo cuts Ozempic, Wegovy prices up to 48% as generics surge